Recent Updates
Recently added Catalysts
CLDX Positive Sentiment

Celldex to Present at Upcoming Investor Conferences

Key Takeaway: Celldex (NASDAQ:CLDX) announced that management will participate in fireside chats at two upcoming investor conferences. The company will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 9, 2026. Additionally, management will speak at the 9th Annual Evercore Healthcare Conference on December 1, 2026. Webcasts of these presentations will be available on the company website for 90 days following each event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Management will participate in two investor conferences.
  • Presentations will be available via webcasts.
  • Celldex focuses on novel antibody-based treatments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
4.3%
average across 8 past catalysts
Cash runway
~35 mo
Low dilution risk
Lead asset
Barzolvolimab
Phase 3 · Chronic Inducible Urticaria

Full Press Release Details

HAMPTON, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming investor conferences:
• The Guggenheim 3rd Annual Healthcare Innovation Conference on November 9, 2026 at 9:00am ET.
• The 9th Annual Evercore Healthcare Conference on December 1, 2026 at 10:50am ET.
The webcasts of the Guggenheim and Evercore presentations will be available on the “Events and Presentations” page of the “Investors” section of the Celldex Website. Replays will be available for 90 days following the event.
About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com.

Company Contacts Sarah Cavanaugh Senior Vice President, Corporate Affairs & Administration (508) 864-8337 scavanaugh@celldex.com

Frequently Asked Questions

When will Celldex present at the investor conferences?

Celldex will present on November 9 and December 1, 2026.

Where can I watch the Celldex presentations?

The presentations will be available on Celldex's website.

How long will the webcasts be available?

Replays of the webcasts will be available for 90 days.

What is Celldex's focus in immunology?

Celldex focuses on novel antibody-based treatments for various disorders.

Last updated: Nov 4, 2026